Suppose this wasn't the case. The news headlines would of course be "Experimental drugs being tested on minorities". That would be a PR disaster. It's safer to steer clear of minorities.
Essentially, the drug companies can't win. People will find something to complain about. Either minorities are getting neglected, or they are being abused as lab subjects.
Essentially, the drug companies can't win. People will find something to complain about. Either minorities are getting neglected, or they are being abused as lab subjects.